Population pharmacokinetic modeling of plasma Δ9‐tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration-Reference-Cited by-同舟云学术

Population pharmacokinetic modeling of plasma Δ9‐tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration

Published:2020-01-20 Issue:3 Volume:86 Page:611-619
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Sempio Cristina¹,Huestis Marilyn A.²,Mikulich‐Gilbertson Susan K.³⁴,Klawitter Jost¹,Christians Uwe¹,Henthorn Thomas K.¹⁵^ORCID

Affiliation:

1. Department of Anesthesiology University of Colorado School of Medicine Aurora Colorado USA

2. The Lambert Center for the Study of Medicinal Cannabis and Hemp, The Institute for Emerging Health Professions Thomas Jefferson University Philadelphia Pennsylvania USA

3. Department of Psychiatry, Division of Substance Dependence University of Colorado School of Medicine Aurora Colorado USA

4. Department of Biostatistics and Informatics University of Colorado School of Public Health Aurora Colorado USA

5. Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Aurora Colorado USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14170

Reference26 articles.

1. Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis

2. Potential harms from legalization of recreational cannabis use in Canada

3. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clin

4. Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol

5. Estimating the Time of Last Cannabis Use from Plasma Δ9-Tetrahydrocannabinol and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol Concentrations

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Compartment Model to Study the Pharmacokinetics of Medical THC after Oral Administration;Computation;2024-06-11

2. Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled Δ9-Tetrahydrocannabinol Cannabis Market Products in Occasional and Daily Users;Therapeutic Drug Monitoring;2024-05-23

3. State cannabis laws and cannabis positivity among fatally injured drivers;Injury Epidemiology;2024-04-11

4. A Compartment Pharmacokinetics Model of THC and Its Metabolites after Smoking;2023 IEEE 5th Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability;2023-11-22

5. A two-sample approach to retrograde extrapolation of blood THC concentrations – Is it feasible?;Forensic Science International;2023-11